HCmed Innovations Co (TPE:6934) Quick Ratio: 4.58 (As of Dec. 2025) — 17% Below Median


TPE:6934 HCmed Innovations Co Ltd TPE:6934
11 GF Score
Price NT$68.00
! 4 Warning Signs
View Full Analysis

What is HCmed Innovations Co Quick Ratio?

HCmed Innovations Co TPE:6934 -2.16% 11 Quick Ratio is 4.58 as of Dec. 2025, which is 17% below its 10-year median of 5.55. GuruFocus rates TPE:6934 with a GF Score™ of 11/100. The stock has 4 warning signs investors should review. Among 854 Medical Devices & Instruments companies, HCmed Innovations Co ranks better than 80.8% on this metric.

The quick ratio measures a company's ability to meet its short-term obligations with its most liquid assets. It is calculated as a company's Total Current Assets excludes Total Inventories divides by its Total Current Liabilities. HCmed Innovations Co's quick ratio for the quarter that ended in Dec. 2025 was 4.58.

HCmed Innovations Co has a quick ratio of 4.58. It generally indicates good short-term financial strength.

The historical rank and industry rank for HCmed Innovations Co's Quick Ratio or its related term are showing as below:

TPE:6934' s Quick Ratio Range Over the Past 10 Years
Min: 2.53   Med: 5.55   Max: 6.25
Current: 4.58

During the past 5 years, HCmed Innovations Co's highest Quick Ratio was 6.25. The lowest was 2.53. And the median was 5.55.

TPE:6934's Quick Ratio is ranked better than
80.8% of 854 companies
in the Medical Devices & Instruments industry
Industry Median: 1.885 vs TPE:6934: 4.58

HCmed Innovations Co  (TPE:6934) Quick Ratio Explanation

The quick ratio is more conservative than the Current Ratio because it excludes inventories from current assets. The ratio derives its name presumably from the fact that assets such as cash and marketable securities are quick sources of cash. Inventories generally take time to be converted into cash, and if they have to be sold quickly, the company may have to accept a lower price than book value of these inventories. As a result, they are justifiably excluded from assets that are ready sources of immediate cash.

In general, low or decreasing quick ratios generally suggest that a company is over-leveraged, struggling to maintain or grow sales, paying bills too quickly or collecting receivables too slowly. On the other hand, a high or increasing quick ratio generally indicates that a company is experiencing solid top-line growth, quickly converting receivables into cash, and easily able to cover its financial obligations. Such companies often have faster inventory turnover and cash conversion cycles.

The higher the quick ratio, the better the company's liquidity position.


HCmed Innovations Co Quick Ratio Related Terms


HCmed Innovations Co Quick Ratio Historical Data

* Premium members only.

The historical data trend for HCmed Innovations Co's Quick Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

HCmed Innovations Co Quick Ratio Chart

HCmed Innovations Co Annual Data
Trend Dec21 Dec22 Dec23 Dec24 Dec25
Quick Ratio
2.53 6.25 6.13 5.55 4.58

HCmed Innovations Co Quarterly Data
Dec21 Dec22 Jun23 Dec23 Jun24 Sep24 Dec24 Jun25 Sep25 Dec25
Quick Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 5.55 10.69 6.46 4.58

TPE:6934 vs ABT, SYK, MDT: Quick Ratio Comparison

For the Medical Devices subindustry, HCmed Innovations Co's Quick Ratio, along with its competitors' market caps and Quick Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


HCmed Innovations Co Quick Ratio vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, HCmed Innovations Co's Quick Ratio distribution charts can be found below:

* The bar in red indicates where HCmed Innovations Co's Quick Ratio falls into.


TPE:6934
11GF Score
HCmed Innovations Co Ltd TPE:6934
Quick Ratio is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

HCmed Innovations Co Quick Ratio Calculation

The quick ratio measures a company's ability to meet its short-term obligations with its most liquid assets. For this reason, the ratio excludes inventories from current assets.

HCmed Innovations Co's Quick Ratio for the fiscal year that ended in Dec. 2025 is calculated as

Quick Ratio (A: Dec. 2025 )=(Total Current Assets-Total Inventories)/Total Current Liabilities
=(287.555-13.646)/59.769
=4.58

HCmed Innovations Co's Quick Ratio for the quarter that ended in Dec. 2025 is calculated as

Quick Ratio (Q: Dec. 2025 )=(Total Current Assets-Total Inventories)/Total Current Liabilities
=(287.555-13.646)/59.769
=4.58

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Quick Ratio →
What does a Quick Ratio of 4.58 mean?
HCmed Innovations Co (TPE:6934) has a Quick Ratio of 4.58 as of Dec. 2025. Quick ratio is the ratio of current assets less inventory to current liabilities. View historical data on HCmed Innovations Co and its competitors. This is 17% below median its historical median of 5.55. Over the past decade, HCmed Innovations Co's Quick Ratio has ranged from 2.53 to 6.25. According to the industry distribution chart, HCmed Innovations Co ranks #164 out of 854 companies in the Medical Devices & Instruments industry, placing it in the top 19.2%.
Is HCmed Innovations Co's Quick Ratio too high?
HCmed Innovations Co's current Quick Ratio of 4.58 is 17% below median its 10-year median of 5.55. Over the past 10 years, this metric has ranged from a low of 2.53 to a high of 6.25. The Medical Devices & Instruments industry median Quick Ratio is 1.89. HCmed Innovations Co's value of 4.58 is 143% above this industry median. Based on the distribution chart, HCmed Innovations Co ranks #164 out of 854 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, HCmed Innovations Co has a GF Score™ of 11/100, reflecting its overall financial health beyond just this single metric.
How does HCmed Innovations Co's Quick Ratio compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, HCmed Innovations Co ranks #164 out of 854 companies for Quick Ratio. This places HCmed Innovations Co in the top 19% of its industry — outperforming the majority of peers. The industry median Quick Ratio is 1.89. HCmed Innovations Co's value of 4.58 is 143% above this benchmark. Historically, HCmed Innovations Co's own Quick Ratio has ranged from 2.53 to 6.25 over the past decade. While the company's 10-year median is 5.55 vs. the industry median of 1.89, HCmed Innovations Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Quick Ratio for a Medical Devices & Instruments company?
The median Quick Ratio among Medical Devices & Instruments companies is 1.89, based on 854 companies in the industry. Companies in the top quartile (top 25%) have a Quick Ratio significantly above this median, while those in the bottom quartile fall well below. However, Quick Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. HCmed Innovations Co's current Quick Ratio of 4.58 is 143% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Quick Ratio mean?
A high Quick Ratio can signal that a stock is expensive relative to its fundamentals. Quick ratio is the ratio of current assets less inventory to current liabilities. View historical data on HCmed Innovations Co and its competitors. For the Medical Devices & Instruments industry, the median Quick Ratio is 1.89 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. HCmed Innovations Co's current Quick Ratio is 4.58, which is 17% below median its own 10-year median of 5.55. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is HCmed Innovations Co stock overvalued right now?
HCmed Innovations Co (TPE:6934) has a current Quick Ratio of 4.58. The current Quick Ratio is 4.58, which is 17% below median its 10-year median of 5.55 and 143% above the Medical Devices & Instruments industry median of 1.89. HCmed Innovations Co's overall GF Score™ is 11/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Quick Ratio calculated?
Quick Ratio is calculated from a company's financial statements. For HCmed Innovations Co (TPE:6934), the current Quick Ratio is 4.58 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

HCmed Innovations Co Business Description

Address Dunhua S. Road, Rm.B, 10th floor., No.319, Sec.2, Taipei, TWN, 106033
HCmed Innovations Co Ltd is engaged in designing, developing, manufacturing and selling drug delivery system. It is focused on inhalation therapy to create integrated drug nebulizer combination products featuring nebulization therapeutic drugs that include small molecule synthetics and large molecule biologics, as either solutions, suspensions, and even difficult-to-deliver high viscosity drugs. Its product includes Pulmogine. Geographically, the company operates in America, Europe, Asian and African regions.
11GF Score

Get the complete analysis for TPE:6934

Quick Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

NT$68.00
Price